Regenerative Therapies to Restore Interneuron Disturbances in Experimental Models of Encephalopathy of Prematurity
Open Access
- 28 December 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (1) , 211
Abstract
Encephalopathy of Prematurity (EoP) is a major cause of morbidity in (extreme) preterm neonates. Though the majority of EoP research has focused on failure of oligodendrocyte maturation as an underlying pathophysiological mechanism, recent pioneer work has identified developmental disturbances in inhibitory interneurons to contribute to EoP. Here we investigated interneuron abnormalities in two experimental models of EoP and explored the potential of two promising treatment strategies, namely intranasal mesenchymal stem cells (MSCs) or insulin-like growth factor I (IGF1), to restore interneuron development. In rats, fetal inflammation and postnatal hypoxia led to a transient increase in total cortical interneuron numbers, with a layer-specific deficit in parvalbumin (PV)+ interneurons. Additionally, a transient excess of total cortical cell density was observed, including excitatory neuron numbers. In the hippocampal cornu ammonis (CA) 1 region, long-term deficits in total interneuron numbers and PV+ subtype were observed. In mice subjected to postnatal hypoxia/ischemia and systemic inflammation, total numbers of cortical interneurons remained unaffected; however, subtype analysis revealed a global, transient reduction in PV+ cells and a long-lasting layer-specific increase in vasoactive intestinal polypeptide (VIP)+ cells. In the dentate gyrus, a long-lasting deficit of somatostatin (SST)+ cells was observed. Both intranasal MSC and IGF1 therapy restored the majority of interneuron abnormalities in EoP mice. In line with the histological findings, EoP mice displayed impaired social behavior, which was partly restored by the therapies. In conclusion, induction of experimental EoP is associated with model-specific disturbances in interneuron development. In addition, intranasal MSCs and IGF1 are promising therapeutic strategies to aid interneuron development after EoP.Keywords
This publication has 87 references indexed in Scilit:
- Cognitive trajectories from infancy to early adulthood following birth before 26 weeks of gestation: a prospective, population-based cohort studyArchives of Disease in Childhood, 2017
- White matter injury in the preterm infant: pathology and mechanismsActa Neuropathologica, 2017
- Impaired oligodendrocyte maturation in preterm infants: Potential therapeutic targetsProgress in Neurobiology, 2016
- Brain injury in premature neonates: A primary cerebral dysmaturation disorder?Annals of Neurology, 2014
- Imaging the premature brain: ultrasound or MRI?Neuroradiology, 2013
- Neurobiology of injury to the developing brainNature Reviews Neurology, 2010
- Brain injury in premature infants: a complex amalgam of destructive and developmental disturbancesThe Lancet Neurology, 2009
- Long-Term Medical and Social Consequences of Preterm BirthNew England Journal of Medicine, 2008
- Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort studyThe Lancet, 2008
- Pathogenesis of cerebral white matter injury of prematurityArchives of Disease in Childhood - Fetal and Neonatal Edition, 2008